The 39th PM Society Awards, supported by headline sponsor Avalere Health, were held on 14 March 2025 at the JW Marriott ...

Healthcare is built around patients, but too often, their voices are an afterthought. Truly patient-focused medicine isn’t ...

Amgen has shared new data from a late-stage trial of its B cell-depleting therapy Uplizna (inebilizumab-cdon) in adults with ...

The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and ...

AstraZeneca (AZ) and Ionis Pharmaceuticals’ Wainzua (eplontersen) has been approved by the European Commission (EC) to treat ...

UK prime minister Sir Keir Starmer has unveiled plans to bring management of the NHS “back into democratic control” by abolishing NHS England. Sir Keir said the move will return the NHS “to the heart ...

The Drug Safety Research Unit (DSRU) has announced the appointment of Linda Härmark as its new director.

Struggling to quantify the value of your medical education platform and prove its ROI? Join our upcoming Pharma-exclusive webinar to learn real-work strategies and tips for developing a Med Ed ...

This World Kidney Day (13 March 2025), Boehringer Ingelheim (BI) has announced a new initiative aimed at detecting, ...

Beyond AMR, Biogen is planning to initiate phase 3 trials of felzartamab in two kidney diseases, IgA nephropathy and primary ...

The National Institute for Health and Care Excellence (NICE) has recommended Gideon Richter’s Ryeqo (relugolix, estradiol and ...